These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31572396)

  • 1. Toll-Like Receptor 7 Activation Enhances CD8+ T Cell Effector Functions by Promoting Cellular Glycolysis.
    Li Q; Yan Y; Liu J; Huang X; Zhang X; Kirschning C; Xu HC; Lang PA; Dittmer U; Zhang E; Lu M
    Front Immunol; 2019; 10():2191. PubMed ID: 31572396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR-Mediated Innate Production of IFN-γ by CD8+ T Cells Is Independent of Glycolysis.
    Salerno F; Guislain A; Cansever D; Wolkers MC
    J Immunol; 2016 May; 196(9):3695-705. PubMed ID: 27016606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses.
    Heer AK; Shamshiev A; Donda A; Uematsu S; Akira S; Kopf M; Marsland BJ
    J Immunol; 2007 Feb; 178(4):2182-91. PubMed ID: 17277123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
    Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W
    J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation.
    Yao S; Buzo BF; Pham D; Jiang L; Taparowsky EJ; Kaplan MH; Sun J
    Immunity; 2013 Nov; 39(5):833-45. PubMed ID: 24211184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential requirements for IRF4 in the clonal expansion and homeostatic proliferation of naive and memory murine CD8
    Miyakoda M; Honma K; Kimura D; Akbari M; Kimura K; Matsuyama T; Yui K
    Eur J Immunol; 2018 Aug; 48(8):1319-1328. PubMed ID: 29745988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.
    Finlay DK; Rosenzweig E; Sinclair LV; Feijoo-Carnero C; Hukelmann JL; Rolf J; Panteleyev AA; Okkenhaug K; Cantrell DA
    J Exp Med; 2012 Dec; 209(13):2441-53. PubMed ID: 23183047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of TLR7 in CD8(+) T cells leads to TLR7-mediated activation and accessory cell-dependent IFN-gamma production in HIV type 1 infection.
    Song Y; Zhuang Y; Zhai S; Huang D; Zhang Y; Kang W; Li X; Liu Q; Yu Q; Sun Y
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1287-95. PubMed ID: 19954299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.
    Breckpot K; Escors D; Arce F; Lopes L; Karwacz K; Van Lint S; Keyaerts M; Collins M
    J Virol; 2010 Jun; 84(11):5627-36. PubMed ID: 20237085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model.
    Duffau P; Menn-Josephy H; Cuda CM; Dominguez S; Aprahamian TR; Watkins AA; Yasuda K; Monach P; Lafyatis R; Rice LM; Kenneth Haines G; Gravallese EM; Baum R; Richez C; Perlman H; Bonegio RG; Rifkin IR
    Arthritis Rheumatol; 2015 Dec; 67(12):3146-57. PubMed ID: 26315890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 7 stimulation promotes autoimmune diabetes in the NOD mouse.
    Lee AS; Ghoreishi M; Cheng WK; Chang TY; Zhang YQ; Dutz JP
    Diabetologia; 2011 Jun; 54(6):1407-16. PubMed ID: 21340621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When Toll-like receptor and T-cell receptor signals collide: a mechanism for enhanced CD8 T-cell effector function.
    Geng D; Zheng L; Srivastava R; Asprodites N; Velasco-Gonzalez C; Davila E
    Blood; 2010 Nov; 116(18):3494-504. PubMed ID: 20696947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells.
    Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
    J Leukoc Biol; 2010 Jan; 87(1):117-25. PubMed ID: 19843574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal integration by Akt regulates CD8 T cell effector and memory differentiation.
    Kim EH; Sullivan JA; Plisch EH; Tejera MM; Jatzek A; Choi KY; Suresh M
    J Immunol; 2012 May; 188(9):4305-14. PubMed ID: 22467649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor-2/7-mediated T cell activation: An innate potential to augment CD8
    Freen-van Heeren JJ
    Scand J Immunol; 2021 May; 93(5):e13019. PubMed ID: 33377182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulation through TLR2 Drives Polyfunctional CD8
    Salerno F; Freen-van Heeren JJ; Guislain A; Nicolet BP; Wolkers MC
    J Immunol; 2019 Feb; 202(3):714-723. PubMed ID: 30578304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR2 Stimulation Increases Cellular Metabolism in CD8
    Zhang E; Ma Z; Li Q; Yan H; Liu J; Wu W; Guo J; Zhang X; Kirschning CJ; Xu H; Lang PA; Yang D; Dittmer U; Yan H; Lu M
    J Immunol; 2019 Dec; 203(11):2872-2886. PubMed ID: 31636238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
    McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
    Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.